André Volland

546 total citations
10 papers, 277 citations indexed

About

André Volland is a scholar working on Infectious Diseases, Neurology and Genetics. According to data from OpenAlex, André Volland has authored 10 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 2 papers in Neurology and 2 papers in Genetics. Recurrent topics in André Volland's work include SARS-CoV-2 and COVID-19 Research (6 papers), Virus-based gene therapy research (2 papers) and Viral Infections and Outbreaks Research (2 papers). André Volland is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), Virus-based gene therapy research (2 papers) and Viral Infections and Outbreaks Research (2 papers). André Volland collaborates with scholars based in Austria, United States and Italy. André Volland's co-authors include Dorotheé von Laer, Janine Kimpel, Annika Rössler, Lydia Riepler, Wegene Borena, Emmanuel Heilmann, Francesco Costacurta, Bernhard Rupp, Reuben S. Harris and Matteo Pavan and has published in prestigious journals such as Journal of Molecular Biology, Scientific Reports and Science Translational Medicine.

In The Last Decade

André Volland

10 papers receiving 275 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
André Volland Austria	8	191	61	38	30	25	10	277
Filippo Dragoni Italy	13	238 1.2×	29 0.5×	17 0.4×	53 1.8×	20 0.8×	31	354
Ali Adel Dawood Iraq	9	186 1.0×	76 1.2×	28 0.7×	19 0.6×	26 1.0×	47	302
Anil Mathew Tharappel United States	10	170 0.9×	96 1.6×	19 0.5×	46 1.5×	23 0.9×	15	320
Marion Sevajol France	3	355 1.9×	139 2.3×	49 1.3×	48 1.6×	66 2.6×	3	450
Carlota Fernandez-Antunez Denmark	10	279 1.5×	75 1.2×	68 1.8×	51 1.7×	46 1.8×	17	341
Austin N. Spratt Sweden	5	327 1.7×	119 2.0×	35 0.9×	21 0.7×	31 1.2×	6	393
Huanying Zhou United States	10	300 1.6×	66 1.1×	42 1.1×	55 1.8×	41 1.6×	10	389
Ahmed Magdy Khalil Egypt	8	161 0.8×	41 0.7×	37 1.0×	111 3.7×	21 0.8×	19	231
Ageng Wiyatno Indonesia	9	152 0.8×	57 0.9×	13 0.3×	53 1.8×	21 0.8×	14	258
Christian S. Stevens United States	5	262 1.4×	92 1.5×	27 0.7×	31 1.0×	42 1.7×	11	339

Countries citing papers authored by André Volland

Since Specialization

Citations

This map shows the geographic impact of André Volland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Volland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Volland more than expected).

Fields of papers citing papers by André Volland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Volland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Volland. The network helps show where André Volland may publish in the future.

Co-authorship network of co-authors of André Volland

This figure shows the co-authorship network connecting the top 25 collaborators of André Volland. A scholar is included among the top collaborators of André Volland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Volland. André Volland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Riepler, Lydia, Kathrin Held, André Volland, et al.. (2023). Therapeutic Efficacy of a VSV-GP-based Human Papilloma Virus Vaccine in a Murine Cancer Model. Journal of Molecular Biology. 435(13). 168096–168096. 5 indexed citations

Heilmann, Emmanuel, Francesco Costacurta, Seyed Arad Moghadasi, et al.. (2022). SARS-CoV-2 3CL ^pro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376. Science Translational Medicine. 15(678). eabq7360–eabq7360. 69 indexed citations

Lackner, Michaela, Annika Rössler, André Volland, et al.. (2022). N-chlorotaurine is highly active against respiratory viruses including SARS-CoV-2 (COVID-19) in vitro. Emerging Microbes & Infections. 11(1). 1293–1307. 15 indexed citations

Heilmann, Emmanuel, Francesco Costacurta, Stephan Geley, et al.. (2022). A VSV-based assay quantifies coronavirus Mpro/3CLpro/Nsp5 main protease activity and chemical inhibition. Communications Biology. 5(1). 391–391. 16 indexed citations

Knabl, Ludwig, Tanmay Mitra, Janine Kimpel, et al.. (2021). High SARS-CoV-2 seroprevalence in children and adults in the Austrian ski resort of Ischgl. Communications Medicine. 1(1). 4–4. 38 indexed citations

Lee, Hye‐Kyung, Ludwig Knabl, André Volland, et al.. (2021). Immune transcriptomes of highly exposed SARS-CoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community. Scientific Reports. 11(1). 4243–4243. 13 indexed citations

Volland, André, et al.. (2021). Heparan sulfate proteoglycans serve as alternative receptors for low affinity LCMV variants. PLoS Pathogens. 17(10). e1009996–e1009996. 21 indexed citations

Wagner, Gabriel E., André Volland, Michaela Lipp, et al.. (2021). A Novel High-Throughput Nanopore-Sequencing-Based Strategy for Rapid and Automated S-Protein Typing of SARS-CoV-2 Variants. Viruses. 13(12). 2548–2548. 7 indexed citations

Riepler, Lydia, Annika Rössler, André Volland, et al.. (2020). Comparison of Four SARS-CoV-2 Neutralization Assays. Vaccines. 9(1). 13–13. 84 indexed citations

10.

Hernández-Rodríguez, Jessica, André Volland, Marek Juda, et al.. (2018). Effect of imidacloprid ingestion on immune responses to porcine reproductive and respiratory syndrome virus. Scientific Reports. 8(1). 11615–11615. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact